Kcentra 1,000 unit vials
Ended Awarded
- Contract number
- SPE2DB25FZL36
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,857
Award facts
- Contract value 100% obligated
- $9,857.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $9,857.28 to DMS Pharmaceutical Group Inc. for 1,000 unit vials of Kcentra on September 27, 2025, with an ultimate completion date of October 20, 2025. This firm fixed-price delivery order represents no set-aside designation and will be performed in Park Ridge, Illinois, where DMS Pharmaceutical Group maintains its headquarters. Kcentra is a vitamin K-dependent clotting factor complex used to reverse anticoagulation in emergency medical situations, making it a critical pharmaceutical supply for military and federal healthcare facilities.
This delivery order is issued under DMS Pharmaceutical Group's larger indefinite delivery contract with the Defense Logistics Agency valued at $499,999,999 through November 2026, which authorizes the agency to procure a comprehensive range of pharmaceutical products for Department of Defense medical facilities nationwide. DMS Pharmaceutical Group is a woman-owned small business pharmaceutical wholesaler specializing in distributing branded and generic prescription drugs, biologics, and medical consumables to federal healthcare systems. The company has established itself as a significant supplier within the federal pharmaceutical supply chain, leveraging its small business status to compete effectively while maintaining a robust portfolio of delivery orders across various medication categories and medical products supporting military health operations globally.
Quick answers
Who was awarded contract SPE2DB25FZL36?
SPE2DB25FZL36 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 27, 2025.
How much is contract SPE2DB25FZL36 worth?
The government has obligated $9,857 on SPE2DB25FZL36.
Is contract SPE2DB25FZL36 an order under another contract?
Yes. SPE2DB25FZL36 is a delivery order under SPE2DB20D9329, an indefinite delivery contract.
Was contract SPE2DB25FZL36 competed?
The extent of competition for SPE2DB25FZL36 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award